Cerebrospinal Fluid Aβ Biomarkers Predict Recurrent Hemorrhage and Identify Cerebral Amyloid Angiopathy in Patients With Lobar Hemorrhage.

The predictive performance of probable CAA defined by the Boston criteria version 1.5 did not reach statistical significance in this cohort, showing a recurrent hemorrhage rate of 15.1 versus 4.00 events per 100 patient‐years (IRR, 2.4 [95% CI, 0.4–22.3]; P =0.329).

also in 111,027 other papers